Tirzepatide-based evidence from the SURPASS (Researching Tirzepatide in Patients with Type 2 Diabetes for Glycemic Control and Weight Management) trials (SURPASS-1 NCT03954834 and SURPASS-5 NCT04039503) demonstrated dose-dependent, significant weight loss over 40 weeks compared with placebo, along with reductions in BMI and waist circumference [62, 63]
[1] [2] Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish with continued use
This suggests that thermodynamic parameters (e.g., water activity, surface tension, and solution density) assumed by the ideal solution theory are accurate to use in Eqs
Gallagher EJ, Alikhani N, Tobin-Hess A, Blank J, Buffin NJ, Zelenko Z et al
A combination of tranexamic acid and glutathione, a powerful anti-oxidant, that blocks melanin to brighten skin around the eyes as well as improve uneven skin tone
& Azzaoui, F.-Z